Skip to main content

Entrada Therapeutics, Inc.

TRDA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001689375

In the last 90 days, Entrada Therapeutics, Inc. insiders filed 0 open-market purchases and 7 sales; 128 institutions reported holding it in 13F filings for Q2 2026, worth $214.4M in total; no superinvestor holds it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Entrada Therapeutics, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
7 filings
4 insiders, $5.92M in total
Insiders trading
4
Net value
−$5.92M
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Entrada Therapeutics, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Entrada Therapeutics, Inc.
NameTitleLast reported holdingLast filingFilings, past year
MPM Bioventures 2018, L.P.10% Owner3,885,115IndirectSep 9, 20264
MPM BioVentures 2018 GP LLC10% Owner3,885,115IndirectSep 9, 20264
MPM BioVentures 2018 LLC10% Owner3,885,115IndirectSep 9, 20264
Gadicke Ansbert10% Owner3,885,115IndirectSep 9, 20264
Evnin Luke10% Owner3,885,115IndirectSep 9, 20264
Foley Todd10% Owner3,885,115IndirectSep 9, 20264
MPM BioVentures 2014, L.P.10% Owner3,885,115IndirectSep 9, 20264
MPM BioVentures 2014 (B), L.P.10% Owner3,885,115IndirectSep 9, 20264
MPM Asset Management Investors BV2014 LLC10% Owner3,885,115IndirectSep 9, 20264
MPM Bioventures 2018 (B), L.P.10% Owner3,885,115IndirectSep 9, 20264
MPM Asset Management Investors BV2018 LLC10% Owner3,885,115IndirectSep 9, 20264
MPM BioVentures 2014 LLC10% Owner3,885,115IndirectSep 9, 20264
MPM BioVentures 2014 GP LLC10% Owner3,885,115IndirectSep 9, 20264
Doshi DipalCEO517,290Sep 3, 20262
Dowden Nathan JPresident & COO196,060Sep 3, 20264
Sethuraman NatarajanPresident, Research & Develop.214,238Sep 3, 20263
Wentworth Kory JamesChief Financial Officer117,277Sep 3, 20266
Parmar KushDirector2,691,337IndirectAug 10, 20264
Rocklage Scott M10% Owner2,783,781Aug 10, 20263
Schwab Andrew J.10% Owner2,783,781Aug 10, 20263
5AM Ventures V, L.P.10% Owner2,783,781Aug 10, 20263
5AM Opportunities I, L.P.10% Owner2,783,781Aug 10, 20263
5AM Opportunities I (GP), LLC10% Owner2,783,781Aug 10, 20263
5AM Partners V, LLC10% Owner2,783,781Aug 10, 20263
Kim Peter SDirector117,412Jun 12, 20261
Thistle MaryDirector–Jun 12, 20261
Zeiher Bernhardt GDirector5,000IndirectJun 12, 20262
Chapman GinaDirector–Jun 12, 20261
Radhakrishnan MahaDirector–Jun 12, 20261
Baker Julian10% Owner4,691,392IndirectNov 24, 20252
Baker Felix10% Owner4,691,392IndirectNov 24, 20252
Baker Bros. Advisors LP10% Owner4,691,392IndirectNov 24, 20252
Baker Bros. Advisors (GP) LLC10% Owner4,691,392IndirectNov 24, 20252
Kreher NerissaChief Medical Officer40,037Sep 6, 20230
Crowley John FDirector5,000Jun 12, 20230
Nuechterlein CaroleDirector–Jun 6, 20220
Roche Holding Ltd10% Owner2,813,525IndirectNov 4, 20210
Roche Finance Ltd10% Owner2,813,525IndirectNov 4, 20210
Redmile Group, LLC10% Owner1,954,420IndirectNov 4, 20210
Green Jeremy10% Owner1,954,420IndirectNov 4, 20210
Redmile Biopharma Investments III, L.P.10% Owner1,954,420IndirectNov 4, 20210

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
May 20, 2024 (view filing)May 16-204 daysSethuraman NatarajanChief Scientific OfficerSSale−19.0K$15.16−$287.7K−9.1%190.1K after3 lots10b5-1
May 20, 2024 (view filing)May 16-174 daysDoshi DipalCEOSSale−3.00K$15.04−$45.1K−0.9%337.4K after2 lots10b5-1
May 10, 2024 (view filing)May 8-92 daysKim Peter SDirectorPPurchase+4.48K$14.14+$63.3K+7.1%67.4K after2 lots
Apr 10, 2024 (view filing)Apr 82 daysKim Peter SDirectorPPurchase+2.60K$13.57+$35.3K+4.3%62.9K after
Apr 1, 2024 (view filing)Mar 284 daysKim Peter SDirectorPPurchase+1.51K$13.75+$20.8K+2.6%60.3K after
Mar 26, 2024 (view filing)Mar 22-264 daysKim Peter SDirectorPPurchase+9.05K$13.58+$122.9K+18.2%58.8K after3 lots
Mar 21, 2024 (view filing)Mar 19-212 daysKim Peter SDirectorPPurchase+2.73K$12.81+$35.0K+5.8%49.8K after3 lots
Mar 8, 2024 (view filing)Mar 62 daysWentworth Kory JamesChief Financial OfficerSSale−4.09K$12.31−$50.3K−5.2%74.2K after10b5-1
Mar 8, 2024 (view filing)Mar 62 daysDowden Nathan JPresident & COOSSale−1.83K$12.32−$22.5K−1.3%137.2K after10b5-1
Feb 20, 2024 (view filing)Feb 155 daysDoshi DipalCEOSSale−1.00K$15.00−$15.0K−0.4%243.3K after10b5-1
Jan 18, 2024 (view filing)Jan 162 daysDoshi DipalCEOSSale−1.00K$15.99−$16.0K−0.4%244.3K after10b5-1
Dec 26, 2023 (view filing)Dec 21-265 daysWentworth Kory JamesChief Financial OfficerSSale−12.5K$15.59−$194.8K−20.1%49.6K after4 lots10b5-1
Dec 22, 2023 (view filing)Dec 202 daysDoshi DipalPresident and CEOSSale−1.00K$15.00−$15.0K−0.4%245.3K after10b5-1
Nov 13, 2023 (view filing)Nov 13Same dayDoshi DipalPresident and CEOSSale−1.00K$16.23−$16.2K−0.4%246.3K after10b5-1
Oct 19, 2023 (view filing)Oct 172 daysDoshi DipalPresident and CEOSSale−1.00K$15.00−$15.0K−0.4%247.3K after10b5-1
Sep 15, 2023 (view filing)Sep 132 daysDoshi DipalPresident and CEOSSale−1.00K$15.00−$15.0K−0.4%248.3K after10b5-1
Sep 6, 2023 (view filing)Sep 6Same dayWentworth Kory JamesChief Financial OfficerSSale−950$13.48−$12.8K−1.9%49.6K after2 lots10b5-1
Sep 6, 2023 (view filing)Sep 6Same dayKreher NerissaChief Medical OfficerSSale−892$13.47−$12.0K−2.2%40.0K after2 lots10b5-1
Sep 6, 2023 (view filing)Sep 6Same dayDowden Nathan JChief Operating OfficerSSale−972$13.47−$13.1K−2.0%48.2K after2 lots10b5-1
Aug 16, 2023 (view filing)Aug 142 daysDoshi DipalPresident and CEOSSale−1.00K$15.67−$15.7K−0.5%201.1K after10b5-1
Aug 4, 2023 (view filing)Aug 2-42 daysKreher NerissaChief Medical OfficerSSale−26.7K$14.76−$394.2K−49.6%27.1K after5 lots10b5-1
Jul 12, 2023 (view filing)Jul 10-112 daysWentworth Kory JamesChief Financial OfficerSSale−10.0K$17.99−$179.9K−21.4%36.7K after2 lots10b5-1
Jul 12, 2023 (view filing)Jul 10-112 daysDowden Nathan JChief Operating OfficerSSale−7.10K$18.03−$127.9K−16.7%35.4K after2 lots10b5-1
Jul 12, 2023 (view filing)Jul 10-112 daysSethuraman NatarajanChief Scientific OfficerSSale−17.9K$18.03−$322.4K−10.4%153.4K after2 lots10b5-1
Jun 23, 2023 (view filing)Jun 212 daysWentworth Kory JamesChief Financial OfficerSSale−17.5K$15.01−$262.6K−38.5%28.0K after2 lots10b5-1
Jun 22, 2023 (view filing)Jun 20-222 daysDowden Nathan JChief Operating OfficerSSale−16.0K$15.42−$246.4K−27.3%42.5K after2 lots10b5-1
May 1, 2023 (view filing)Apr 274 daysDoshi DipalPresident and CEOSSale−2.00K$13.71−$27.4K−1.0%202.1K after10b5-1
Apr 19, 2023 (view filing)Apr 172 daysDoshi DipalPresident and CEOSSale−2.09K$18.01−$37.7K−1.0%204.1K after10b5-1
Apr 19, 2023 (view filing)Apr 172 daysSethuraman NatarajanChief Scientific OfficerSSale−3.96K$18.00−$71.3K−2.3%171.3K after10b5-1
Mar 29, 2023 (view filing)Mar 272 daysDoshi DipalPresident and CEOSSale−2.00K$14.72−$29.4K−0.8%255.8K after2 lots10b5-1
Mar 3, 2023 (view filing)Mar 21 dayWentworth Kory JamesChief Financial OfficerSSale−1.75K$10.52−$18.4K−4.0%42.2K afterFrom original2 lots
Mar 3, 2023 (view filing)Mar 21 dayKreher NerissaChief Medical OfficerSSale−1.64K$10.56−$17.3K−3.8%41.3K afterFrom original2 lots
Mar 2, 2023 (view filing)Feb 282 daysDoshi DipalPresident and CEOSSale−2.00K$12.00−$24.0K−1.2%161.8K after
Jan 30, 2023 (view filing)Jan 273 daysDoshi DipalPresident and CEOSSale−2.00K$12.00−$24.0K−1.2%163.8K after
Jan 10, 2023 (view filing)Jan 91 dayDoshi DipalPresident and CEOSSale−2.41K$15.02−$36.2K−1.4%165.8K after
Jan 3, 2023 (view filing)Dec 30, 20224 daysKreher NerissaChief Medical OfficerSSale−5.20K$13.45−$69.9K−25.1%15.5K after
Dec 29, 2022 (view filing)Dec 27-292 daysDoshi DipalPresident and CEOSSale−14.6K$15.02−$219.1K−8.0%168.2K after4 lots
Dec 12, 2022 (view filing)Dec 84 daysWentworth Kory JamesChief Financial OfficerSSale−4.55K$18.95−$86.2K−21.6%16.5K after
Dec 6, 2022 (view filing)Dec 2-54 daysWentworth Kory JamesChief Financial OfficerSSale−3.11K$18.19−$56.6K−15.9%16.5K after2 lots
Nov 30, 2022 (view filing)Nov 282 daysDoshi DipalPresident and CEOSSale−2.00K$13.91−$27.8K−1.1%182.8K after
Nov 18, 2022 (view filing)Nov 162 daysWentworth Kory JamesChief Financial OfficerSSale−200$18.10−$3.62K−1.2%16.5K after
Nov 2, 2022 (view filing)Oct 312 daysDowden Nathan JChief Operating OfficerSSale−2.10K$24.05−$50.5K−4.4%45.3K after
Oct 27, 2022 (view filing)Oct 25-262 daysKreher NerissaChief Medical OfficerSSale−13.0K$21.27−$276.5K−38.6%20.7K after5 lots
Oct 27, 2022 (view filing)Oct 252 daysDowden Nathan JChief Operating OfficerSSale−9.35K$20.77−$194.2K−16.5%47.4K after3 lots
Oct 27, 2022 (view filing)Oct 25-272 daysDoshi DipalPresident and CEOSSale−14.1K$20.80−$292.5K−7.1%184.8K after4 lots
Oct 24, 2022 (view filing)Oct 20-244 daysDowden Nathan JChief Operating OfficerSSale−6.08K$18.66−$113.4K−9.7%56.7K after4 lots
Oct 24, 2022 (view filing)Oct 20-244 daysDoshi DipalPresident and CEOSSale−5.94K$18.64−$110.7K−2.9%198.9K after4 lots
Sep 28, 2022 (view filing)Sep 26-282 daysDoshi DipalPresident and CEOSSale−10.6K$15.25−$161.4K−4.9%204.8K after5 lots
Sep 28, 2022 (view filing)Sep 26-282 daysKreher NerissaChief Medical OfficerSSale−8.59K$15.29−$131.4K−29.3%20.7K after4 lots
Sep 28, 2022 (view filing)Sep 262 daysDowden Nathan JChief Operating OfficerSSale−1.54K$15.45−$23.9K−2.4%62.8K after2 lots